Dissemination of a localized cutaneous infection with Mycobacterium chelonae under immunosuppressive treatment [7]

Archives of Dermatology

Volumn 143, Issue 7, 2007, Pages 951-952

  Hoetzenecker, Wolfram ^a   Ulmer, Anja ^b   Klingel, Karin ^b   Kempf, Volkhard A J ^b   Schanz, Stefan ^b   Metzler, Gisela ^b   Fierlbeck, Gerhard ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LINEZOLID; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; VANCOMYCIN;

ADULT; ANEMIA; BREAST; CASE REPORT; DEBRIDEMENT; DRUG WITHDRAWAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MONOTHERAPY; MYCOBACTERIUM CHELONEI; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SKIN ABSCESS; SKIN BIOPSY; SKIN INFECTION; THROMBOCYTOPENIA;

ACETAMIDES; ANTI-INFECTIVE AGENTS; CLARITHROMYCIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MIDDLE AGED; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM INFECTIONS, ATYPICAL; OXAZOLIDINONES; SKIN ULCER;

EID: 34447522130     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.143.7.951     Document Type: Letter

References (8)

1. Popper HH, Klemen H, Hoefler G, Winter E. Presence of mycobacterial DNA in sarcoidosis. Hum Pathol. 1997;28(7):796-800.
2. Kyle SD, Porter WM. Mycobacterium chelonae infection successfully treated with oral clarithromycin and linezolid. Br J Dermatol. 2004;151(5):1101.
3. Brown-Elliott BA, Wallace RJ, Blinkhorn R, Crist CJ, Mann LB. Successful treatment of disseminated Mycobacterium chelonae infection with linezolid. Clin Infect Dis. 2001;33(8):1433-1434.
4. Levine N, Rothschild JG. Treatment of Mycobacterium chelonae infection with controlled localized heating. J Am Acad Dermatol. 1991;24(5, pt 2):867-870.
5. Franck N, Cabie A, Villette B, et al. Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin. J Am Acad Dermatol. 1993;28(6):1019-1021.
6. Wallace RJ Jr, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis. 1992;166(2):405-412.
7. Uslan DZ, Kowalski TJ, Wengenack NL, Virk A, Wilson JW. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Arch Dermatol. 2006;142(10):1287-1292.
8. Vemulapalli RK, Cantey JR, Steed LL, Knapp TL, Thielman NM. Emergence of resistance to clarithromycin during treatment of disseminated cutaneous Mycobacterium chelonae infection: case report and literature review. J Infect. 2001;43(3):163-168.